First, we found that treatment of patient-derived melanoma CTCs with hydrogen peroxide (H2O2) (0–25 μM)—a major component of ROS—caused a dose-dependent increase of NRF2 target gene expression along with downstream anti-oxidant CAT, GSS, and TXNRD1 effector genes (Figure 7A). Here, TXNRD1 is linked to melanoma.